The fentanyl crisis continues to pose significant challenges for law enforcement and healthcare professionals, with over 21,000 pounds of fentanyl seized at U.S. borders last year alone—an amount potent enough to kill over 4 billion people. As policymakers implement new trade and border enforcement measures, the need for rapid, accurate, and scalable testing solutions has never been more critical. 

Through this partnership, ViiMed and SAFE Health are introducing a comprehensive, technology-driven solution that enables faster, more precise fentanyl detection and real-time reporting for public health agencies, law enforcement, and border security teams. 

The ViiMed + SAFE Health Solution 

This joint offering integrates SAFE Health’s patented Computer Vision Machine Learning (CVML) diagnostic reader with ViiMed’s secure, low-code/no-code SaaS platform, delivering: 

Rapid & Reliable Drug Detection

The Powder Tracer Test provides highly accurate results in under five minutes, detecting fentanyl, xylazine, cocaine, methamphetamine, THC, amphetamines, benzodiazepines, and other illicit substances on surfaces. 

Real-Time Data Reporting & Monitoring

The solution seamlessly integrates with government and public health IT systems, enabling instantaneous reporting and regulatory compliance with agencies such as NIST, HIPAA, SOC-2, and HITRUST. 

Secure & Scalable Infrastructure

Engineered for AWS GovCloud, the platform meets the highest security standards, supporting Protected Health Information (PHI), Personally Identifiable Information (PII), and Sensitive But Unclassified (SBU/CUI) data types. 

Interoperable & Automated Workflows

ViiMed’ dynamic EMR and automated CareFlows ensure that test results are traceable, auditable, and actionable, streamlining operations for law enforcement, healthcare providers, and policymakers. 

Cost-Effective & U.S.-Based Manufacturing

The low cost per unit and domestic production of the Powder Tracer Test provides a scalable and sustainable alternative to traditional chemical field tests.